HomeEconomySun Pharmaceutical Industries denied entry to its key US market after the...

Sun Pharmaceutical Industries denied entry to its key US market after the drug regulator placed

Sun Pharmaceutical Industries Ltd’s supply of drugs from its Gujarat factory could be denied entry to its key US market after the drug regulator placed an import warning on the facility, the drugmaker said on Thursday. The Food and Drug Administration’s (FDA) notice on imports is effectively a ban, meaning any future shipments of products made at the Halol plant in Gujarat could be refused until the facility is brought into compliance with the regulator’s current GMP standards.

Shares of Sun Pharma fell 3.9% in the steepest intraday decline since late May and were the top losers on the blue-chip Nifty 50 index. “The company continues to cooperate with the US FDA and will take all necessary steps to resolve these issues and to ensure that the regulator is fully satisfied with the company’s corrective action,” Sun Pharma said. The FDA has excluded 14 products from the import warning under certain conditions.

It was not immediately clear what the conditions are and what corrective actions the FDA has asked the company to take. “Removing import alerts is very difficult and several companies are still not able to bring their facilities back into compliance after 7-10 years,” said Shrikant Akolkar of Asian Markets Securities after Sun Pharma cut its revenue and revenue outlook and cut its targets price up 4.5% to Rs 1,156.

The focus will now shift to the Sun Mohali facility, Akolkar added. The plant was classified as “official action indicated” following a November inspection, meaning regulatory or administrative action will be recommended. The Halol plant received the same inspection classification in August after the FDA conducted 10 observations. Halol’s US market shipments, including 14 excluded products, contributed approximately 3% to Sun Pharma’s consolidated revenue in the year ending March 2022 per company.

Read Now:<strong>Tata Group-owned airline Air India today said it will invest $400 million to refurbish the cabin interiors</strong>

[responsivevoice_button buttontext="Listen This Post" voice="Hindi Female"]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

RELATED ARTICLES

Trending News

Ranbir Kapoor and Alia Bhatt Plan to Name ₹250 Crore Bungalow After Daughter Raha Kapoor

Ranbir Kapoor, Alia Bhatt, and Neetu Kapoor were recently spotted together at their under-construction bungalow in Mumbai's Bandra area....

PM Narendra Modi and Bill Gates Discuss AI, Technology Future, and Women Empowerment

New Delhi: Prime Minister Narendra Modi and Microsoft co-founder Bill Gates engaged in discussions covering a broad spectrum of...

Unraveling the Mystery of the Sun’s Bizarre Rotation with Varying Spin Rates Across Different Latitudes

The Sun's rotation is a peculiar phenomenon that has long baffled scientists. Unlike what one might expect, its surface...

Hardik Pandya, Mumbai Indians, and the Quandary of IPL Allegiance, coupled with MI’s defeat against Sunrisers Hyderabad

The recent Mumbai Indians vs. Gujarat Titans match witnessed Hardik Pandya facing criticism and scrutiny, reflecting underlying tensions within...